Ironwood Pharmaceuticals | IRWD - Operating Expenses



Ironwood Pharmaceuticals reported $57.33M in Operating Expenses for its fiscal quarter ending in December of 2024.


Operating Expenses Change Date
Acadia Pharmaceuticals USD 232.19M 7.16M Jun/2025
Agios Pharmaceuticals USD 139.51M 24.16M Jun/2025
Almirall EUR 517.43M 265.53M Jun/2025
Alnylam Pharmaceuticals USD 789.89M 213.78M Jun/2025
Amarin USD 58.77M 56.06M Mar/2025
Ardelyx USD 112.06M 4.06M Jun/2025
Astellas Pharma JPY 413.25B 17.48B Jun/2025
AstraZeneca USD 10.95B 1.04B Jun/2025
Charles River Laboratories USD 899.8M 9.7M Jun/2025
Exact Sciences USD 813.23M 10.44M Jun/2025
Halozyme Therapeutics USD 123.28M 48K Jun/2025
Incyte USD 904.7M 56.97M Jun/2025
Ironwood Pharmaceuticals USD 57.33M 8.63M Dec/2024
MacroGenics USD 59M 23.06M Jun/2025
Moderna USD 1.04B 113M Jun/2025
Myriad Genetics USD 224.9M 24.7M Mar/2025
Pacira USD 170.87M 3.93M Jun/2025
PTC Therapeutics USD 213.73M 7.86M Jun/2025
Sarepta Therapeutics USD 495.51M 549.73M Jun/2025
Takeda JPY 922.12B 206.21B Jun/2025
Ultragenyx Pharmaceutical USD 274.38M 7.85M Jun/2025